State-wise Status of Multi-Drug Resistant (MDR)/ Rifampicin Resistant (RR) with Additional Resistance Patients Diagnosis and Treatment under National Tuberculosis Elimination Programme (NTEP) in North East States of India (2020) | |||||||||
States | MDR/RR With Additional Resistance Diagnosed | FQ/SLI/InhA/Z Resistance Patients Initiated on Treatment (Other than XDR) | FQ/SLI/InhA/Z Resistance Patients Initiated on Longer Oral Regimen (Other than XDR) | ||||||
FQ Resistance | SLI Resistance | InhA Resistance | Z Resistance | FQ/SLI/InhA/Z Resistance Detected (Other than XDR) | |||||
No. | %age | No. | %age | ||||||
Arunachal Pradesh | |||||||||
Assam | |||||||||
Manipur | |||||||||
Meghalaya | |||||||||
Mizoram | |||||||||
Nagaland | |||||||||
Sikkim | |||||||||
Tripura | |||||||||
North-East India | |||||||||
India |